Pipeline

Pipeline

Indication Pre-Clinical Feasibility Pilot Pivotal FDA Cleared
Axillary Sweating
Palmar Hyperhidrosis
Plantar Hyperhidrosis
Facial Hyperhidrosis

Candesant aims to meet an unmet need in the world of excessive and bothersome sweating by offering an uncomplicated in-office treatment. 

Our targeted alkali thermolysis (TAT) can be configured to treat a number of afflicted body areas. We are starting with excessive axillary (underarm) sweating as it represents the greatest opportunity to address an unmet need. This will be followed by other applications to meet additional areas for excessive and bothersome sweating and hyperhidrosis.

Scroll to Top